Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT04561466
BÉFINOHL
Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy
Type: Interventional
Status of the trial: Active, Recruiting
Orphan Drug Recognition: Yes
Inclusion
- Opening Date: 2019-03-01
- Closing Date: 2022-03-01
Criteria
Children: No
Adults: Yes
Funder Type: public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Neuro-Ophthalmology Rare Diseases (WG2)
This ERN is supported by:
